BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 12141718)

  • 1. Onset of action, efficacy, and safety of fexofenadine 60 mg/pseudoephedrine 120 mg versus placebo in the Atlanta allergen exposure unit.
    Berkowitz RB; Woodworth GG; Lutz C; Weiler K; Weiler J; Moss M; Meeves S
    Ann Allergy Asthma Immunol; 2002 Jul; 89(1):38-45. PubMed ID: 12141718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Onset of action of fexofenadine hydrochloride 60 mg/pseudoephedrine hydrochloride 120 mg in subjects aged 12 years with moderate to severe seasonal allergic rhinitis: a pooled analysis of two single-dose, randomized, double-blind, placebo-controlled allergen exposure unit studies.
    Berkowitz RB; McCafferty F; Lutz C; Bazelmans D; Godfrey P; Meeves S; Liao Y; Georges G
    Clin Ther; 2006 Oct; 28(10):1658-69. PubMed ID: 17157121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fexofenadine HCl 60 mg/ pseudoephedrine HCl 120 mg has a 60-minute onset of action in the treatment of seasonal allergic rhinitis symptoms, as assessed in an allergen exposure unit.
    Berkowitz RB; McCafferty F; Lutz C; Bazelmans D; Godfrey P; Meeves S; Liao Y; Georges G
    Allergy Asthma Proc; 2004; 25(5):335-43. PubMed ID: 15603207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Onset-of-action for antihistamine and decongestant combinations during an outdoor challenge.
    Georgitis JW; Meltzer EO; Kaliner M; Weiler J; Berkowitz R
    Ann Allergy Asthma Immunol; 2000 Apr; 84(4):451-9. PubMed ID: 10795655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of azelastine nasal spray in seasonal allergic rhinitis patients who remain symptomatic after treatment with fexofenadine.
    LaForce CF; Corren J; Wheeler WJ; Berger WE;
    Ann Allergy Asthma Immunol; 2004 Aug; 93(2):154-9. PubMed ID: 15328675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Onset of action, efficacy, and safety of a single dose of fexofenadine hydrochloride for ragweed allergy using an environmental exposure unit.
    Day JH; Briscoe MP; Welsh A; Smith JN; Clark A; Ellis AK; Mason J
    Ann Allergy Asthma Immunol; 1997 Dec; 79(6):533-40. PubMed ID: 9433370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of clemastine-pseudoephedrine-acetaminophen versus pseudoephedrine-acetaminophen in the treatment of seasonal allergic rhinitis in a 1-day, placebo-controlled park study.
    Meltzer EO; Casale TB; Gold MS; O'Connor R; Reitberg D; del Rio E; Weiler JM; Weiler K
    Ann Allergy Asthma Immunol; 2003 Jan; 90(1):79-86. PubMed ID: 12546342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy and safety of fexofenadine HCl and pseudoephedrine, alone and in combination, in seasonal allergic rhinitis.
    Sussman GL; Mason J; Compton D; Stewart J; Ricard N
    J Allergy Clin Immunol; 1999 Jul; 104(1):100-6. PubMed ID: 10400846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the combinations of fexofenadine-pseudoephedrine and loratadine-montelukast in the treatment of seasonal allergic rhinitis.
    Moinuddin R; deTineo M; Maleckar B; Naclerio RM; Baroody FM
    Ann Allergy Asthma Immunol; 2004 Jan; 92(1):73-9. PubMed ID: 14756468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of acrivastine plus pseudoephedrine for symptomatic relief of seasonal allergic rhinitis due to mountain cedar.
    Williams BO; Hull H; McSorley P; Frosolono MF; Sanders RL
    Ann Allergy Asthma Immunol; 1996 May; 76(5):432-8. PubMed ID: 8630717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of acrivastine with pseudoephedrine in treatment of allergic rhinitis due to ragweed.
    Dockhorn RJ; Williams BO; Sanders RL
    Ann Allergy Asthma Immunol; 1996 Feb; 76(2):204-8. PubMed ID: 8595542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative efficacy of cetirizine and fexofenadine for seasonal allergic rhinitis, 5-12 hours postdose, in the environmental exposure unit.
    Day JH; Briscoe MP; Rafeiro E; Ratz JD; Ellis AK; Frankish CW; Chapman D; deGuia EC; Kramer B; Warner C
    Allergy Asthma Proc; 2005; 26(4):275-82. PubMed ID: 16270720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of fexofenadine hydrochloride for treatment of seasonal allergic rhinitis.
    Bernstein DI; Schoenwetter WF; Nathan RA; Storms W; Ahlbrandt R; Mason J
    Ann Allergy Asthma Immunol; 1997 Nov; 79(5):443-8. PubMed ID: 9396979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of seasonal allergic rhinitis: a comparison of a combination tablet of terfenadine and pseudoephedrine with the individual ingredients.
    Backhouse CI; Rosenberg RM; Fidler C
    Br J Clin Pract; 1990 Jul; 44(7):274-9. PubMed ID: 1976379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cetirizine, loratadine, or placebo in subjects with seasonal allergic rhinitis: effects after controlled ragweed pollen challenge in an environmental exposure unit.
    Day JH; Briscoe M; Widlitz MD
    J Allergy Clin Immunol; 1998 May; 101(5):638-45. PubMed ID: 9600501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of oral fexofenadine in children with seasonal allergic rhinitis--a pooled analysis of three studies.
    Meltzer EO; Scheinmann P; Rosado Pinto JE; Bachert C; Hedlin G; Wahn U; Finn AF; Ruuth E
    Pediatr Allergy Immunol; 2004 Jun; 15(3):253-60. PubMed ID: 15209959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cross-over comparison of acrivastine, pseudoephedrine and their combination in seasonal allergic rhinitis.
    Meran A; Morse J; Gibbs TG
    Rhinology; 1990 Mar; 28(1):33-40. PubMed ID: 1970907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of cetirizine and terfenadine versus placebo in the symptomatic management of seasonal allergic rhinitis.
    Lockey RF; Widlitz MD; Mitchell DQ; Lumry W; Dockhorn R; Woehler T; Grossman J
    Ann Allergy Asthma Immunol; 1996 May; 76(5):448-54. PubMed ID: 8630719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of an H3 receptor antagonist (PF-03654746) with fexofenadine on reducing allergic rhinitis symptoms.
    Stokes JR; Romero FA; Allan RJ; Phillips PG; Hackman F; Misfeldt J; Casale TB
    J Allergy Clin Immunol; 2012 Feb; 129(2):409-12, 412.e1-2. PubMed ID: 22196768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative onset of action and symptom relief with cetirizine, loratadine, or placebo in an environmental exposure unit in subjects with seasonal allergic rhinitis: confirmation of a test system.
    Day JH; Briscoe M; Rafeiro E; Chapman D; Kramer B
    Ann Allergy Asthma Immunol; 2001 Dec; 87(6):474-81. PubMed ID: 11770694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.